ShiftPixy (NASDAQ:PIXY) stock is on the move Friday after the company announced plans to use ChatGPT for recruiting and hiring.
ShiftPixy notes that this will have it integrate the artificial intelligence (AI) into its platform. That will allow the company to better manage how it “finds, hires, and retains its national workforce.”
According to ShiftPixy, adding ChatGPT to its platform will speed up hiring with its analytical capabilities. The AI is capable of quickly “analyze worker experience, job descriptions, and other candidate-related data.” This will help the company to choose the best candidates for jobs.
To go along with that, ShiftPixy will also make use of the AI for its food-ordering brands. The chatbot’s abilities will make it easier for customers to get help while ordering. That includes assistance with questions, feedback and preferences.
Scott Absher, co-founder and CEO of ShiftPixy, said the following about the news:
“ShiftPixy’s platform on its own has been a powerful pivot in staffing industry technology, and this integration of OpenAI’s ChatGPT will take it to the next level. The company’s national staffing clients can expect faster fill rates and better worker engagement, leading to better outcomes for all stakeholders.”
PIXY Stock Reactions Today
Despite the ChatGPT announcement, shares of PIXY stock aren’t climbing higher. Instead, the company’s shares have fallen 9.2% as of Friday morning. That comes alongside 182,000 shares changing hands. For comparison, the company’s daily average trading volume is about 102,000 shares.
Investors keeping an eye out for more recent stock market news are in the right place!
InvestorPlace has all of the hottest stock market coverage traders need to know about on Friday! A few examples include why shares of Boeing (NYSE:BA), Nektar Therapeutics (NASDAQ:NKTR) and SELLAS Life Sciences (NASDAQ:SLS) stock are in the news today. All of that info is ready to go at the links below!
More Friday Stock Market News
- BA Stock Alert: Boeing Halts Deliveries of 787 Dreamliners
- Why Is Nektar Therapeutics (NKTR) Stock Down 39% Today?
- Why Is SELLAS Life Sciences (SLS) Stock Down 38% Today?
On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this fact and warn readers of the risks.
Read More: Penny Stocks — How to Profit Without Getting Scammed
On the date of publication, William White did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.